315 related articles for article (PubMed ID: 21426372)
21. A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis.
De Soyza A; Pavord I; Elborn JS; Smith D; Wray H; Puu M; Larsson B; Stockley R
Eur Respir J; 2015 Oct; 46(4):1021-32. PubMed ID: 26341987
[TBL] [Abstract][Full Text] [Related]
22. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.
Souza DG; Bertini R; Vieira AT; Cunha FQ; Poole S; Allegretti M; Colotta F; Teixeira MM
Br J Pharmacol; 2004 Sep; 143(1):132-42. PubMed ID: 15302676
[TBL] [Abstract][Full Text] [Related]
23. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats.
Auten RL; Richardson RM; White JR; Mason SN; Vozzelli MA; Whorton MH
J Pharmacol Exp Ther; 2001 Oct; 299(1):90-5. PubMed ID: 11561067
[TBL] [Abstract][Full Text] [Related]
24. Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signalling.
Müller-Edenborn B; Frick R; Piegeler T; Schläpfer M; Roth-Z'graggen B; Schlicker A; Beck-Schimmer B
Br J Anaesth; 2015 Jan; 114(1):143-9. PubMed ID: 24989774
[TBL] [Abstract][Full Text] [Related]
25. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.
White JR; Lee JM; Young PR; Hertzberg RP; Jurewicz AJ; Chaikin MA; Widdowson K; Foley JJ; Martin LD; Griswold DE; Sarau HM
J Biol Chem; 1998 Apr; 273(17):10095-8. PubMed ID: 9553055
[TBL] [Abstract][Full Text] [Related]
26. Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2.
Busch-Petersen J; Carpenter DC; Burman M; Foley J; Hunsberger GE; Kilian DJ; Salmon M; Mayer RJ; Yonchuk JG; Tal-Singer R
J Pharmacol Exp Ther; 2017 Aug; 362(2):338-346. PubMed ID: 28611093
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil recruitment by chemokines Cxcl1/KC and Cxcl2/MIP2: Role of Cxcr2 activation and glycosaminoglycan interactions.
Sawant KV; Sepuru KM; Lowry E; Penaranda B; Frevert CW; Garofalo RP; Rajarathnam K
J Leukoc Biol; 2021 Apr; 109(4):777-791. PubMed ID: 32881070
[TBL] [Abstract][Full Text] [Related]
28. A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.
Vieira SM; Lemos HP; Grespan R; Napimoga MH; Dal-Secco D; Freitas A; Cunha TM; Verri WA; Souza-Junior DA; Jamur MC; Fernandes KS; Oliver C; Silva JS; Teixeira MM; Cunha FQ
Br J Pharmacol; 2009 Oct; 158(3):779-89. PubMed ID: 19702783
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
Nicholls DJ; Wiley K; Dainty I; MacIntosh F; Phillips C; Gaw A; Mårdh CK
J Pharmacol Exp Ther; 2015 May; 353(2):340-50. PubMed ID: 25736418
[TBL] [Abstract][Full Text] [Related]
30. Facilitation of Allergic Sensitization and Allergic Airway Inflammation by Pollen-Induced Innate Neutrophil Recruitment.
Hosoki K; Aguilera-Aguirre L; Brasier AR; Kurosky A; Boldogh I; Sur S
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):81-90. PubMed ID: 26086549
[TBL] [Abstract][Full Text] [Related]
31. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.
Hu N; Westra J; Rutgers A; Doornbos-Van der Meer B; Huitema MG; Stegeman CA; Abdulahad WH; Satchell SC; Mathieson PW; Heeringa P; Kallenberg CG
Arthritis Res Ther; 2011; 13(6):R201. PubMed ID: 22152684
[TBL] [Abstract][Full Text] [Related]
32. Peripheral blood neutrophils are hyperresponsive to IL-8 and Gro-alpha in cryptogenic fibrosing alveolitis.
Glynn PC; Henney EM; Hall IP
Eur Respir J; 2001 Sep; 18(3):522-9. PubMed ID: 11589350
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects--a double blind, randomized, placebo-controlled, cross-over clinical trial.
Kirsten A; Watz H; Kretschmar G; Pedersen F; Bock D; Meyer-Sabellek W; Magnussen H
Pulm Pharmacol Ther; 2011 Oct; 24(5):555-8. PubMed ID: 21514398
[TBL] [Abstract][Full Text] [Related]
34. Cell-specific regulatory effects of CXCR2 on cholestatic liver injury.
Konishi T; Schuster RM; Goetzman HS; Caldwell CC; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G773-G783. PubMed ID: 31604030
[TBL] [Abstract][Full Text] [Related]
35. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
[TBL] [Abstract][Full Text] [Related]
36. CXCR2 antagonist attenuates neutrophil transmigration into brain in a murine model of LPS induced neuroinflammation.
Wu F; Chen X; Zhai L; Wang H; Sun M; Song C; Wang T; Qian Z
Biochem Biophys Res Commun; 2020 Aug; 529(3):839-845. PubMed ID: 32616311
[TBL] [Abstract][Full Text] [Related]
37. Plant-derived verbascoside and isoverbascoside regulate Toll-like receptor 2 and 4-driven neutrophils priming and activation.
Dimitrova P; Alipieva K; Stojanov K; Milanova V; Georgiev MI
Phytomedicine; 2019 Mar; 55():105-118. PubMed ID: 30668420
[TBL] [Abstract][Full Text] [Related]
38. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
39. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation.
Chapman RW; Minnicozzi M; Celly CS; Phillips JE; Kung TT; Hipkin RW; Fan X; Rindgen D; Deno G; Bond R; Gonsiorek W; Billah MM; Fine JS; Hey JA
J Pharmacol Exp Ther; 2007 Aug; 322(2):486-93. PubMed ID: 17496165
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2.
Casilli F; Bianchini A; Gloaguen I; Biordi L; Alesse E; Festuccia C; Cavalieri B; Strippoli R; Cervellera MN; Di Bitondo R; Ferretti E; Mainiero F; Bizzarri C; Colotta F; Bertini R
Biochem Pharmacol; 2005 Feb; 69(3):385-94. PubMed ID: 15652230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
